Elucidating the Sugar Tailoring Steps in the Cytorhodin Biosynthetic Pathway.

Anthracycline antitumor cytorhodins X and Y feature a rare 9α-glycoside and 7-dexoy-aglycone. Characterization of the cytorhodin gene cluster from Streptomyces sp. SCSIO 1666 through gene inactivations and metabolite analyses reveals three glycosyltransferases (GTs) involved in the sugar tailoring steps. The duo of CytG1 and CytL effects C-7 glycosylation with l-rhodosamine whereas the iterative GT CytG3 and CytW similarly modifies both C-9 and C-10 positions. CytG2 also acts iteratively by incorporating the second and third sugar moiety into the trisaccharide chains at the C-7 or C-10 position.

[1]  Charles B. Larson,et al.  PCR-Independent Method of Transformation-Associated Recombination Reveals the Cosmomycin Biosynthetic Gene Cluster in an Ocean Streptomycete. , 2017, Journal of natural products.

[2]  Jarmo Niemi,et al.  Divergent evolution of an atypical S-adenosyl-l-methionine–dependent monooxygenase involved in anthracycline biosynthesis , 2015, Proceedings of the National Academy of Sciences.

[3]  Hung‐wen Liu,et al.  Characterization of glycosyltransferase DesVII and its auxiliary partner protein DesVIII in the methymycin/picromycin biosynthetic pathway. , 2010, Biochemistry.

[4]  H. Laatsch,et al.  Naturally Occurring Anthracyclines , 2008 .

[5]  C. Walsh,et al.  Characterization of rhodosaminyl transfer by the AknS/AknT glycosylation complex and its use in reconstituting the biosynthetic pathway of aclacinomycin A. , 2007, Journal of the American Chemical Society.

[6]  J. Rohr,et al.  Insights in the glycosylation steps during biosynthesis of the antitumor anthracycline cosmomycin: characterization of two glycosyltransferase genes , 2006, Applied Microbiology and Biotechnology.

[7]  C. Walsh,et al.  AknT is an activating protein for the glycosyltransferase AknS in L-aminodeoxysugar transfer to the aglycone of aclacinomycin A. , 2005, Chemistry & biology.

[8]  L. Gianni,et al.  Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.

[9]  K. Chater,et al.  Lambda red-mediated genetic manipulation of antibiotic-producing Streptomyces. , 2004, Advances in applied microbiology.

[10]  G. Challis,et al.  PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Yoshimoto,et al.  Cloning and characterization of a glycosyltransferase gene involved in the biosynthesis of anthracycline antibiotic beta-rhodomycin from Streptomyces violaceus. , 2002, FEMS microbiology letters.

[12]  C. Hutchinson,et al.  A two-plasmid system for the glycosylation of polyketide antibiotics: bioconversion of ε-rhodomycinone to rhodomycin D , 1999 .

[13]  D. Hoffmann,et al.  The new cytotoxic antibiotic cytorhodin X, an unusual anthracyclinone-9 alpha-glycoside. , 1992, The Journal of antibiotics.

[14]  T. Takeuchi,et al.  Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262. , 1991, The Journal of antibiotics.

[15]  M. Li,et al.  Structural studies on rhodilunancins A and B. , 1986, The Journal of antibiotics.

[16]  H. Shibai,et al.  Production and Isolation of Cosmomycins A, B, C and D: New Differentiation Inducers of Friend Cell F5-5 , 1985 .

[17]  H. Shibai,et al.  The structures of anthracycline antibiotics, cosmomycins A and B , 1985 .

[18]  T. Takeuchi,et al.  New anthracycline derivatives from betaclamycin A. , 1984, The Journal of antibiotics.

[19]  B. Schlegel,et al.  New anthracycline antibiotics produced by interspecific recombinants of streptomycetes. III. Isolation and structure of iremycin. , 1980, The Journal of antibiotics.